Company Rosetta Genomics Ltd. (USA) Nasdaq
Equities
IL0011026494
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
MicroRNA-based Molecular Diagnostic
100.0
%
| 8 | 100.0 % | 9 | 100.0 % | +11.68% |
Sales per region
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
Israel and United States
100.0
%
| 8 | 100.0 % | 9 | 100.0 % | +11.68% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ron Kalfus
DFI | Director of Finance/CFO | 50 | 12-05-23 |
Nicole Massoll
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | 09-12-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,929,860 | 5,929,860 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Rosetta Genomics Ltd.
10 Plaut Street Science Park
76706, Rehovot
+972 73 222 0700
Sector
1st Jan change | Capi. | |
---|---|---|
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |